Study maps enzyme target for potential treatment of rare genetic disorder

Researchers at the Icahn School of Medicine at Mount Sinai mapped the AASS enzyme, a target for treating glutaric aciduria type 1, a rare inherited metabolic disorder. The findings were published in the November 13 issue of Science Advances and reveal how the enzyme's activity is regulated.